BOLT
Bolt Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.56
+6.43%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$3.89
- Revenue estimate
- $68.3K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$4.57
- EPS estimate
- -$3.39
- Revenue actual
- —
- Revenue estimate
- $500.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -5.6%
- Revenue beats (12Q)
- 9
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$3.39 | -$4.57 | Miss -34.81% | — |
| May 12, 2026 | -$2.85 | -$4.31 | Miss -51.23% | — |
| Mar 12, 2026 | -$6.11 | -$3.84 | Beat 37.12% | $2.5M |
| Nov 12, 2025 | -$5.07 | -$3.72 | Beat 26.63% | $2.2M |
| Aug 14, 2025 | -$6.40 | -$4.46 | Beat 30.31% | $1.8M |
| Mar 24, 2025 | -$7.60 | -$7.60 | In line | — |
| Mar 21, 2024 | -$0.47 | -$0.47 | In line | $2.1M |
| Nov 9, 2023 | -$0.49 | -$0.43 | Beat 12.24% | $2.5M |
| May 11, 2023 | -$0.49 | -$0.45 | Beat 8.16% | $1.8M |
| Nov 10, 2022 | -$0.56 | -$0.58 | Miss -3.57% | $2.1M |
| Aug 10, 2022 | -$0.68 | -$0.61 | Beat 10.29% | $1.4M |
| May 12, 2022 | -$0.71 | -$0.64 | Beat 9.86% | $813.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026